SAN RAFAEL, Calif., March 3, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced …
touchEXPERT OPINIONS Clinical management strategies in achondroplasia: Current landscape and new horizons
via touchEndocrinology. Watch three leading experts explore how the pathophysiology of achondroplasia is being targeted …
Lower limb biomechanics during gait in children with Achondroplasia
via Journal of Biomechanics.Damien Kiernan - dkiernan@crc.ie Movement Analysis Laboratory, Central Remedial Clinic, …
Prospects for Pharmaceutical Treatment of Achondroplasia
John B. Cannon, Ph.D Prospects-for-Pharmaceutical-Treatment-of-AchondroplasiaDownload Achondroplasia is a form of …
BridgeBio Pharma’s QED Therapeutics Announces Preclinical Data Demonstrating Potential of Low-Dose Infigratinib in Achondroplasia Data Accepted to ENDO 2020
SAN FRANCISCO, May 11, 2020 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) affiliate QED Therapeutics …